Funder: National Institutes of Health
Due Dates: June 16, 2025 (New) | July 16, 2025 (Renewal/Resubmission/Revision) | October 16, 2025 (New) | November 16, 2025 (Renewal/Resubmission/Revision) | Letters of Intent: May 17, 2025 | September 16, 2025
Funding Amounts: Up to $275,000 direct costs over 2 years; no more than $200,000 in any single year; project period max 2 years.
Summary: Supports exploratory research on neurological and/or mental health effects of infection-associated chronic illnesses, including Long COVID, ME/CFS, POTS, and related conditions.
Key Information: Clinical trial optional; mechanistic focus required; foreign and domestic applicants eligible.